ITEYES, Inc.
KKRX:3728002,700.00
KRW
-150.00
(-5.26%)
ISIN
KR7372800003
Return %
Stock
S&P 500
1Y
-46.22
13.14
3Y
-57.21
80.78
5Y
- -
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Seong-Nam Lee
- Full Time Employees
- 286
- Sector
- Technology services
- Industry
- Packaged software
- Address
- Seoul South Korea
- IPO Date
- Nov 11, 2021
- Website
- iteyes.co.kr
- Similar Companies
- Business
- ITEYES, Inc. is a South Korea-based financial technology and enterprise software company specializing in digital financial solutions, big data platforms, artificial intelligence (AI) systems, and digital healthcare technology. The company develops and implements specialized IT infrastructure and enterprise applications primarily for commercial banks, securities brokerages, asset management companies, public institutions, and healthcare organizations across South Korea. The company operates through three principal business divisions: Financial IT Solutions, AI and Big Data Platforms, and Digital Healthcare. Its Financial IT Solutions portfolio comprises credit evaluation and scoring systems; market, credit, and liquidity risk management systems; asset management and portfolio accounting software; over-the-counter (OTC) derivatives valuation and integrated management systems marketed under the K-GODIS brand; trade repository regulatory reporting platforms known as GODIS-TR; specialized government bond electronic trading systems marketed as BondTRX; and turnkey security token offering (STO) issuance platforms operating under the FASTO-CS brand. Within AI and Big Data Platforms, the company provides GURMWI, a proprietary cloud-native big data analytics, data orchestration, and machine learning platform, alongside the GENAI enterprise generative AI suite, which includes domain-specialized AI engines such as GENAI Fin for financial institutions, GENAI KS, and GENAI CodeBooster, an AI-powered software development assistant. In Digital Healthcare, the company provides personal health record (PHR) management systems, medical MyData collection and Application Programming Interface (API) solutions, the Docpl digital healthcare platform, and GENAI ME, an AI-powered biomedical analytics solution for precision medicine and clinical drug discovery. In addition, the company provides cloud, network, and IT systems integration infrastructure services through its subsidiary CAWAVE Co., Ltd., as well as specialized agricultural data services through its affiliate FarmEyes. In recent strategic developments, ITEYES, Inc. has accelerated its expansion into generative AI, tokenized digital assets, and biomedical technology. The company commercialized FASTO-CS to address the domestic security token issuance market and received Grade 1 Good Software (GS) certification for its GENAI CodeBooster development platform. The company entered into a strategic partnership with Saltlux Inc. to jointly develop and deploy tailored generative AI solutions for the banking and financial services sector, while collaborating with Alchera Inc. to integrate AI-driven facial recognition authentication into financial systems. Expanding its healthcare technology footprint, the company launched its GENAI ME and GenAI-MEDI platforms for AI-assisted drug discovery and precision diagnostics, joined the Busan National University Hospital consortium for regional medical MyData ecosystem deployment, and was selected as a joint research organization for the South Korean Ministry of Health and Welfare's Korea Advanced Research Projects Agency for Health (ARPA-H) precision medicine initiative. Founded on August 7, 2012, ITEYES, Inc. is headquartered in Seoul, South Korea, and is listed on the KOSDAQ market of the Korea Exchange under the ticker symbol 372800.